Additionally, it has been noticed increased levels of C5a in bronchioalveolar fluid of COVID-19 patients with the most severe symptoms, pointing out the role of this protein in the enhanced inflammation developed in severe COVID-19 patients. The gene discussed is C5AR1; the disease is COVID-19.